South Korea Ovarian Cancer Market Size & Outlook, 2025-2033


South Korea Ovarian Cancer Market Insights

  • As highlighted in Reed Intelligence analysis, the South Korea Ovarian Cancer Market, worth USD 10.14 Million in 2024, is forecasted to achieve USD 69.49 Million by 2033.
  • The South Korea market is anticipated to grow at a CAGR of 23.52% during the period 2026–2033.
  • By 2024, Epithelial Tumors represented the largest share of the By Type market size.
  • Germ Cell Tumors is expected to remain the key growth driver within By Type, registering the fastest CAGR during the forecast period.

Other Key Findings


  • In 2024, South Korea represented 0.75% of the overall global Ovarian Cancer Market size.
  • United States is projected to lead the global Ovarian Cancer Market size by 2033.
  • Across Asia Pacific, China is anticipated to hold the dominant position in market size by 2033.
  • Australia is forecasted to expand at the fastest pace in Asia Pacific, attaining USD 90.37 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 10.14 Million
Market Size In 2033 USD 69.49 Million
Largest segment Epithelial Tumors
Units Revenue in USD Million
CAGR 23.52% (2025-2033)
Segmnetation Covered
By Type
  1. Epithelial Tumors
  2. Germ Cell Tumors
  3. Stromal Tumors
  4. Primary Peritoneal Cancer
By Diagnosis
  1. Computed Tomography (C.T.) Scans
  2. Ultrasound
  3. Barium Enema X-Ray
  4. Magnetic Resonance Imaging (MRI) Scans
  5. Chest X-Ray
  6. Positron Emission Tomography (PET) Scan
  7. Other Diagnostic Tests
By Therapeutic Treatment
  1. Chemotherapy
  2. Radiation Therapy
  3. Targeted Therapy
  4. Hormone Therapy
  5. Other Therapeutic Treatments
  6. Surgery
By Route of Administration
  1. Oral
  2. Parenteral
  3. Others
By Drugs
  1. Mitotic Inhibitors
  2. Antirheumatics
  3. Antipsoriatics
  4. VEGF/VEGFR inhibitors
  5. PARP inhibitors
  6. Antineoplastics
  7. Others
By End-User
  1. Hospitals
  2. Diagnostic Centers
  3. Drug Stores
  4. Online Pharmacies
  5. Other End Users
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends